These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 22086760)
1. Effect of lipophilicity on the bioavailability of drugs after percutaneous administration by dissolving microneedles. Ito Y; Yoshimura M; Tanaka T; Takada K J Pharm Sci; 2012 Mar; 101(3):1145-56. PubMed ID: 22086760 [TBL] [Abstract][Full Text] [Related]
2. Two-layered dissolving microneedles for percutaneous delivery of peptide/protein drugs in rats. Fukushima K; Ise A; Morita H; Hasegawa R; Ito Y; Sugioka N; Takada K Pharm Res; 2011 Jan; 28(1):7-21. PubMed ID: 20300802 [TBL] [Abstract][Full Text] [Related]
3. Incidence of low bioavailability of leuprolide acetate after percutaneous administration to rats by dissolving microneedles. Ito Y; Murano H; Hamasaki N; Fukushima K; Takada K Int J Pharm; 2011 Apr; 407(1-2):126-31. PubMed ID: 21277965 [TBL] [Abstract][Full Text] [Related]
4. Method to increase the systemically delivered amount of drug from dissolving microneedles. Ito Y; Hamasaki N; Higashino H; Murakami Y; Miyamoto N; Takada K Chem Pharm Bull (Tokyo); 2013; 61(1):8-15. PubMed ID: 23302582 [TBL] [Abstract][Full Text] [Related]
5. Two-layered dissolving microneedles for percutaneous delivery of sumatriptan in rats. Ito Y; Kashiwara S; Fukushima K; Takada K Drug Dev Ind Pharm; 2011 Dec; 37(12):1387-93. PubMed ID: 21545233 [TBL] [Abstract][Full Text] [Related]
6. Microneedles for transdermal drug delivery. Prausnitz MR Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747 [TBL] [Abstract][Full Text] [Related]
7. Local dermal delivery of cyclosporin A, a hydrophobic and high molecular weight drug, using dissolving microneedles. Jeong HR; Kim JY; Kim SN; Park JH Eur J Pharm Biopharm; 2018 Jun; 127():237-243. PubMed ID: 29432892 [TBL] [Abstract][Full Text] [Related]
8. Sinomenine hydrochloride-loaded dissolving microneedles enhanced its absorption in rabbits. Wu X; Chen Y; Gui S; Wu X; Chen L; Cao Y; Yin D; Ma P Pharm Dev Technol; 2016 Nov; 21(7):787-793. PubMed ID: 26122959 [TBL] [Abstract][Full Text] [Related]
9. Feasibility of microneedles for percutaneous absorption of insulin. Ito Y; Hagiwara E; Saeki A; Sugioka N; Takada K Eur J Pharm Sci; 2006 Sep; 29(1):82-8. PubMed ID: 16828268 [TBL] [Abstract][Full Text] [Related]
10. IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery. Mönkäre J; Reza Nejadnik M; Baccouche K; Romeijn S; Jiskoot W; Bouwstra JA J Control Release; 2015 Nov; 218():53-62. PubMed ID: 26437262 [TBL] [Abstract][Full Text] [Related]
11. Dissolving microneedles for transdermal drug delivery: Advances and challenges. Ita K Biomed Pharmacother; 2017 Sep; 93():1116-1127. PubMed ID: 28738520 [TBL] [Abstract][Full Text] [Related]
12. Novel dissolving microneedles for enhanced transdermal delivery of levonorgestrel: In vitro and in vivo characterization. Yao G; Quan G; Lin S; Peng T; Wang Q; Ran H; Chen H; Zhang Q; Wang L; Pan X; Wu C Int J Pharm; 2017 Dec; 534(1-2):378-386. PubMed ID: 29051119 [TBL] [Abstract][Full Text] [Related]
13. Improvement of transdermal delivery of sumatriptan succinate using a novel self-dissolving microneedle array fabricated from sodium hyaluronate in rats. Wu D; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A Biol Pharm Bull; 2015; 38(3):365-73. PubMed ID: 25757917 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic evaluation of insulin dissolving microneedles in dogs. Fukushima K; Yamazaki T; Hasegawa R; Ito Y; Sugioka N; Takada K Diabetes Technol Ther; 2010 Jun; 12(6):465-74. PubMed ID: 20470231 [TBL] [Abstract][Full Text] [Related]
15. Microneedles: an emerging transdermal drug delivery system. Bariya SH; Gohel MC; Mehta TA; Sharma OP J Pharm Pharmacol; 2012 Jan; 64(1):11-29. PubMed ID: 22150668 [TBL] [Abstract][Full Text] [Related]
16. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility. Wu Y; Qiu Y; Zhang S; Qin G; Gao Y Biomed Microdevices; 2008 Oct; 10(5):601-10. PubMed ID: 18324474 [TBL] [Abstract][Full Text] [Related]
17. Transdermal insulin application system with dissolving microneedles. Ito Y; Nakahigashi T; Yoshimoto N; Ueda Y; Hamasaki N; Takada K Diabetes Technol Ther; 2012 Oct; 14(10):891-9. PubMed ID: 23013202 [TBL] [Abstract][Full Text] [Related]
18. Effect of O-acylmenthol on transdermal delivery of drugs with different lipophilicity. Zhao L; Fang L; Xu Y; Zhao Y; He Z Int J Pharm; 2008 Mar; 352(1-2):92-103. PubMed ID: 18053661 [TBL] [Abstract][Full Text] [Related]
19. Elongate microparticles for enhanced drug delivery to ex vivo and in vivo pig skin. Raphael AP; Primiero CA; Ansaldo AB; Keates HL; Soyer HP; Prow TW J Control Release; 2013 Nov; 172(1):96-104. PubMed ID: 23933236 [TBL] [Abstract][Full Text] [Related]
20. Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats. Katsumi H; Liu S; Tanaka Y; Hitomi K; Hayashi R; Hirai Y; Kusamori K; Quan YS; Kamiyama F; Sakane T; Yamamoto A J Pharm Sci; 2012 Sep; 101(9):3230-8. PubMed ID: 22467424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]